News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
800,258 Results
Type
Article (61222)
Company Profile (334)
Press Release (738681)
Multimedia
Podcasts (144)
Webinars (25)
Section
Business (219619)
Career Advice (2916)
Deals (37777)
Drug Delivery (157)
Drug Development (87406)
Employer Resources (186)
FDA (17786)
Job Trends (16415)
News (373792)
Policy (36682)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2989)
Academic (1)
Accelerated approval (46)
Adcomms (37)
Allergies (181)
Alliances (53662)
ALS (214)
Alzheimer's disease (1892)
Antibody-drug conjugate (ADC) (463)
Approvals (18074)
Artificial intelligence (706)
Autoimmune disease (272)
Automation (54)
Bankruptcy (394)
Best Places to Work (12368)
BIOSECURE Act (21)
Biosimilars (229)
Biotechnology (213)
Bladder cancer (191)
Brain cancer (76)
Breast cancer (755)
Cancer (5934)
Cardiovascular disease (500)
Career advice (2476)
Career pathing (48)
CAR-T (338)
CDC (67)
Celiac Disease (2)
Cell therapy (911)
Cervical cancer (47)
Clinical research (75080)
Collaboration (2153)
Company closure (5)
Compensation (1358)
Complete response letters (94)
COVID-19 (2974)
CRISPR (113)
C-suite (1139)
Cystic fibrosis (155)
Data (7700)
Decentralized trials (3)
Denatured (45)
Depression (180)
Dermatology (75)
Diabetes (602)
Diagnostics (7325)
Digital health (57)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (334)
Drug pricing (229)
Drug shortages (36)
Duchenne muscular dystrophy (293)
Earnings (94877)
Editorial (75)
Employer branding (24)
Employer resources (164)
Events (128429)
Executive appointments (1135)
FDA (21512)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (35)
Funding (1768)
Gene editing (246)
Generative AI (66)
Gene therapy (750)
GLP-1 (1187)
Government (5282)
Grass and pollen (8)
Guidances (407)
Healthcare (20587)
HIV (85)
Huntington's disease (57)
IgA nephropathy (97)
Immunology and inflammation (324)
Immuno-oncology (96)
Indications (174)
Infectious disease (3334)
Inflammatory bowel disease (224)
Inflation Reduction Act (15)
Influenza (142)
Intellectual property (289)
Interviews (562)
IPO (17304)
IRA (58)
Job creations (4373)
Job search strategy (2011)
JPM (67)
Kidney cancer (20)
Labor market (97)
Layoffs (636)
Leadership (47)
Legal (9072)
Liver cancer (107)
Longevity (33)
Lung cancer (795)
Lymphoma (429)
Machine learning (61)
Management (63)
Manufacturing (1037)
MASH (196)
Medical device (15046)
Medtech (15144)
Mergers & acquisitions (21687)
Metabolic disorders (1596)
mRNA (225)
Multiple sclerosis (191)
NASH (24)
Neurodegenerative disease (437)
Neuropsychiatric disorders (118)
Neuroscience (3467)
Neurotech (1)
NextGen: Class of 2026 (7277)
Non-profit (4998)
Now hiring (75)
Obesity (765)
Opinion (345)
Ovarian cancer (212)
Pain (262)
Pancreatic cancer (299)
Parkinson's disease (376)
Partnered (34)
Patents (601)
Patient recruitment (667)
Peanut (66)
People (65112)
Pharmaceutical (70)
Pharmacy benefit managers (34)
Phase 1 (23328)
Phase 2 (32880)
Phase 3 (24595)
Pipeline (8043)
Policy (360)
Postmarket research (3024)
Preclinical (10075)
Press Release (72)
Prostate cancer (302)
Psychedelics (65)
Radiopharmaceuticals (339)
Rare diseases (1128)
Real estate (6678)
Recruiting (77)
Regulatory (27872)
Reports (56)
Research institute (2688)
Resumes & cover letters (458)
Rett syndrome (37)
RNA editing (23)
RSV (94)
Schizophrenia (188)
Series A (298)
Series B (218)
Service/supplier (14)
Sickle cell disease (119)
Special edition (27)
Spinal muscular atrophy (182)
Sponsored (50)
Startups (4034)
State (2)
Stomach cancer (21)
Supply chain (134)
Tariffs (98)
The Weekly (96)
Vaccines (1206)
Venture capital (114)
Weight loss (522)
Women's health (125)
Worklife (23)
Date
Today (211)
Last 7 days (792)
Last 30 days (2946)
Last 365 days (31850)
2026 (10882)
2025 (31757)
2024 (36917)
2023 (41932)
2022 (53214)
2021 (57974)
2020 (56902)
2019 (50261)
2018 (38144)
2017 (35038)
2016 (35239)
2015 (41251)
2014 (35304)
2013 (30869)
2012 (32977)
2011 (33543)
2010 (32164)
Location
Africa (979)
Alabama (94)
Alaska (7)
Arizona (362)
Arkansas (16)
Asia (45600)
Australia (8197)
California (13065)
Canada (3714)
China (1386)
Colorado (564)
Connecticut (580)
Delaware (401)
Europe (102071)
Florida (1940)
Georgia (429)
Hawaii (3)
Idaho (68)
Illinois (1103)
India (91)
Indiana (599)
Iowa (24)
Japan (527)
Kansas (135)
Kentucky (53)
Louisiana (42)
Maine (75)
Maryland (1593)
Massachusetts (9425)
Michigan (373)
Minnesota (732)
Mississippi (7)
Missouri (157)
Montana (35)
Nebraska (29)
Nevada (143)
New Hampshire (90)
New Jersey (3485)
New Mexico (31)
New York (3452)
North Carolina (1740)
North Dakota (9)
Northern California (6493)
Ohio (390)
Oklahoma (24)
Oregon (45)
Pennsylvania (2628)
Puerto Rico (29)
Rhode Island (52)
South America (1361)
South Carolina (87)
South Dakota (2)
Southern California (5133)
Tennessee (212)
Texas (2087)
United States (46663)
Utah (392)
Vermont (1)
Virginia (319)
Washington D.C. (86)
Washington State (1076)
West Virginia (4)
Wisconsin (137)
Wyoming (2)
800,258 Results for "merz aesthetics formerly known as bioform medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Merz Aesthetics® Introduces New BELOTERO® Syringe Offering Greater Precision, Comfort and Ease of Use
November 3, 2025
·
5 min read
Earnings
AstraZeneca Builds Obesity Pipeline On ‘Medical Aspect,’ Not Aesthetics
In an investor call Thursday, AstraZeneca CEO Pascal Soriot outlined his company’s approach to obesity drug development based on “the medical aspect” of weight loss, including driving down visceral fat.
November 6, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Merz Therapeutics Appoints Dan Staner as President, Region Europe
January 30, 2026
·
2 min read
Press Releases
Merz Aesthetics® Receives Approval from Health Canada for RADIESSE® as an Aesthetic Injectable for the Treatment of Moderate Wrinkles in the Décolleté Area
June 5, 2025
·
4 min read
Press Releases
Allergan Aesthetics Releases Findings on the Safety and Efficacy of Repeat TrenibotE Treatments and Data on Medical Weight Loss Aesthetics Patient Behaviors at the 2026 American Academy of Dermatology Meeting (AAD)
March 30, 2026
·
6 min read
Press Releases
Interim Data From Two Ongoing Investigator-initiated Trials Highlight the Role of Sculptra® and Restylane® in Addressing Aesthetic Changes Associated With Weight Loss Medications and Menopause
April 9, 2026
·
9 min read
Press Releases
Merz Therapeutics Submits Application to the European Medicines Agency for New Indication of XEOMIN® in Pediatric Spasticity
January 26, 2026
·
3 min read
Press Releases
Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company
March 23, 2026
·
6 min read
Press Releases
Allergan Aesthetics Reinforces Scientific Differentiation and Leadership with 21 Evidence-Based E-Posters at the 2026 Aesthetic & Anti-Aging Medicine World Congress (AMWC)
March 26, 2026
·
28 min read
Press Releases
Merz Therapeutics to Present Broad Range of Clinical, Real-World and Mechanistic Data at TOXINS 2026
December 8, 2025
·
3 min read
1 of 80,026
Next
